ClinicalTrials.gg
CompletedNCT03272386Updated Sep 25, 2019

Best Verbal Instruction to Obtain Voluntary Pelvic Floor Muscle Contraction

An observational study in Lower Urinary Tract Symptoms, sponsored by Pierre and Marie Curie University. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-09-25.

Sponsored by Pierre and Marie Curie University · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
33
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-13

Among 26 studies in Lower Urinary Tract Symptoms with a site in France — 5 open to participants now, 6 under way, none of them phase 3. Lower Urinary Tract Symptoms · France.

Enrollment
10th of 15
33 · median 72
Started
2017
with 5 others
Observational
15 of 26
1 open now
Registered
8th of 26
by date
Lead sponsor
7 of 26
Pierre and Marie Curie University

Among the 26 studies in Lower Urinary Tract Symptoms with a site in France, this one is the 10th largest by enrollment of the 15 observational ones that give a count, is one of 6 that started in 2017, is one of 15 observational ones, and was the 8th registered.

Lower Urinary Tract Symptoms

417 studies on the registry are indexed under Lower Urinary Tract Symptoms; 110 are open to participants now.

Browse Lower Urinary Tract Symptoms studies →

Open to participants now

5 of the 26 studies in Lower Urinary Tract Symptoms with a site in France are open now. Recruiting first, the newest first:

All 5 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 59 Lower Urinary Tract Symptoms studies recruiting now, 39 (66%) set no upper age limit and 11 (19%) stop at 75 or younger; 7 take children under 18; 11 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 26 studies in Lower Urinary Tract Symptoms with a site in France, or all of them as a file.
02

Study summary

The purpose of this study is to determine the best verbal instruction to obtain a PFMC and to evaluate the understanding and acceptability of the proposed instructions.

Read the detailed description

Pelvic floor muscles contraction (PFMC) is usually recommended for evaluation and treatment of pelvic floor disorders.

In clinical practice, many patients fail to achieve a voluntary PFMC and only about one-third of women perform an ideal PFMC after brief written or verbal instruction. When no PFMC is elicited, it might be explained by an anatomical or neurological issue but also by a lack of understanding of the instructions and / or poor knowledge of the anatomy. Pelvic floor muscles (PFM) evaluation may depends on the method used to elicit and assess the contraction including verbal instructions. There is no current gold standard methodology for quantifying PFM strength and the verbal instructions used to elicit the PFMC are rarely reported in the studies. There is few specific works about the instructions. One recent study report that the pattern of urethral movement is influenced by the instructions used to teach activation of the PFM in men. Another study showed that some specific instructions are most effective in eliciting a correct PFMC in women.

Thus, an appropriate verbal instruction in terms of understanding, social and cultural acceptability, taking into account the anatomical knowledge of the patients, would probably allow a better evaluation of the PFM and even a better efficacy of pelvic floor training.

The purpose of this study is to determine the best verbal instruction to obtain a PFMC and to evaluate the understanding and acceptability of the proposed instructions.

This is a prospective observational study lead in two phases in the Neurourology Department of a University Hospital.

Phase 1: survey carry out the health professionals. Members of the scientific committees of national academic societies in neuro-urology, pelvi-perineology and pelvic-floor neurophysiology would be invited to answer a questionnaire by mail. It will include open questions about the most frequently verbal instructions used to elicit a PFMC. These instructions will be collected, analysed and selected for the second phase.

Phase 2: structured interviews with patients and with non-health professional subjects.

Patients and non-health professionals subjects will be invited to answer a 3-parts questionnaire based on the gender: (i) demographic, social and medical data; (ii) evaluation of the anatomical knowledge of the perineum with a picture of the perineum and a sagittal section of the pelvic area of the corresponding sex. In the third part (iii), the participants will assess the instructions selected in the first phase according to their understanding and their acceptability (good, intermediate, poor). They finally will have to choose the best instruction i.e. which seems to be the more suitable to obtain a PFMC.

Ethics: a local ethics committee approved this study. Since it is an observational study, the participant will have a newsletter.

03

Conditions studied

  • Lower Urinary Tract Symptoms

Keywords

  • pelvic floor muscles
  • instruction
  • assessment
  • acceptability
  • understanding
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients consulting in a tertiary center in neuro-urology.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Follow in neuro-urology
  • Lower urinary tract symptoms

Exclusion criteria

Exclusion Criteria:

  • Can't speak French
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
33 participants (actual)
Patient registry
No

Groups and cohorts

  • Observational study

    Observational study with patients over 18 years old, consulting for lower urinary tract symptoms in a tertiary center are included.

    Other: Observational study

Interventions

  • OtherObservational study

    Completing a questionnaire

06

What researchers measure

Primary outcomes

  1. Description of the instructions used by the professionals

    Qualitative description of the instructions and selection of the most frequent instructions.

    Time frame: 1 day during the consultation

Secondary outcomes

  1. Acceptability, understanding and selection of the best instruction by the subjects

    Description of the selected instructions by the subjects : their acceptability (poor / moderate / good), and understanding (poor / moderate / good) and the best instruction to obtain PFMC (among the selected instructions).

    Time frame: 1 day during the consultation

07

Study locations

1 site
  • Department of neuro-urology, hôpital Tenon
    Paris, 75020, France
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jul 2017 to primary completion in Sep 2017, 1 month.

Of 56 non-industry observational studies under Lower Urinary Tract Symptoms, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 70. This study's 1 month is below that.

Counting every sponsor, half of 61 studies reached it within 33 months; a quarter within 11 and three quarters within 70.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 16, 2017
First posted
Sep 5, 2017
StartActual
Jul 31, 2017
Primary completionActual
Sep 18, 2017
CompletionActual
Sep 29, 2017
Last update
Sep 25, 2019
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 25, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03272386
Lead sponsor
Pierre and Marie Curie University
Responsible party
Gérard Amarenco (Head of Neuro-Urology department, Tenon hospital, Pierre and Marie Curie University) — Principal investigator
First posted
Sep 5, 2017
Start date
Jul 31, 2017
Primary completion
Sep 18, 2017
Completion
Sep 29, 2017
Last update
Sep 25, 2019

Study contacts

Gérard Amarenco, PhD
principal investigator · UPMC, Sorbonne Université, Univ Paris 6, service neuro-urologie, hôpital TENON, Paris

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion